Innoviva, Inc

(NASDAQ:INVA)

Latest On Innoviva, Inc (INVA):

Date/Time Type Description Signal Details
2023-05-24 18:17 ESTNewsInnoviva, Entasis' bacterial pneumonia drug Xacduro wins FDA approvalN/A
2023-05-10 04:00 ESTNewsInnoviva GAAP EPS of $0.51, revenue of $76.37MN/A
2023-04-28 20:42 ESTNewsInnoviva chairman Bickerstaff to step down after annual meetingN/A
2023-04-17 22:45 ESTNewsInnoviva rises 6% on FDA panel backing for bacterial pneumonia drugN/A
2023-03-17 10:16 ESTNewsStill Avoiding InnovivaN/A
2023-02-28 21:36 ESTNewsInnovivaEPS of -$0.98, revenue of $65.8M beats by $6.95MN/A
2023-01-30 15:27 ESTNewsZai Lab's bacterial infection drug gets priority review in ChinaN/A
2022-12-16 05:13 ESTNewsInnoviva: Not Yet Investment WorthyN/A
2022-12-01 12:39 ESTNewsInnoviva's bacterial infection drug gets FDA priority reviewN/A
2022-11-10 01:40 ESTNewsInnoviva GAAP EPS of $2.80, revenue of $67.26MN/A
2022-09-20 00:30 ESTNewsInnoviva Stock? Not Yet. Short Puts? Definitely.N/A
2022-08-24 05:52 ESTNewsInnoviva to acquire La Jolla Pharma for $149M including debtN/A
2022-07-27 20:29 ESTNewsInnoviva GAAP EPS of $0.05, revenue of $108.22MN/A
2022-07-20 23:11 ESTNewsGoldman Sachs starts Innoviva with neutral rating, says royalty portfolio fairly valuedN/A
2022-07-13 17:30 ESTNewsRoyalty Pharma to buy royalty interest in Trelegy drug from Theravance, Innoviva for $1.3BN/A
2022-06-08 20:44 ESTNewsContinuing To Avoid Innoviva, Inc.N/A
2022-06-08 05:03 ESTNewsContinuing To Avoid Innoviva Inc.N/A
2022-05-23 22:33 ESTNewsInnoviva to acquire Entasis Therapeutics for $2.20/shareN/A
2022-04-27 23:52 ESTNewsInnoviva GAAP EPS of $0.20, revenue of $90.06M beats by $3.66MN/A
2022-03-03 13:14 ESTNewsInnoviva prices upsized convertible senior notes offering of $225MN/A
2022-03-02 18:57 ESTNewsInnoviva to raise $200M in convertible senior notes offeringN/A
2022-02-22 06:28 ESTNewsTaking Innoviva Winnings Off The Table, AgainN/A
2022-02-10 10:23 ESTNewsInnoviva GAAP EPS of $0.14, revenue of $107.68MN/A
2022-02-03 13:00 ESTNewsEntasis gains on buyout proposal from InnovivaN/A
2022-01-15 01:26 ESTNewsInnoviva Inc.: Short Puts Are CompellingN/A
2021-10-16 09:20 ESTNewsTaking Profits In Innoviva Inc.N/A
2021-05-04 00:33 ESTNewsEntasis completes initial closing of $20M private placement with InnovivaN/A
2021-04-30 13:11 ESTNewsAlkermes reaches agreement with Sarissa giving activist right to designate board memberN/A
2021-04-29 15:11 ESTNewsInnoviva reports Q1 resultsN/A
2021-03-31 23:01 ESTNewsArbitrator rules no breach in Trelegy agreement between Innoviva and TheravanceN/A
2021-03-21 12:22 ESTNewsAlkermes may see further pressure from activist Sarissa CapitalN/A
2021-03-18 00:40 ESTNewsArmata closes second and final tranche of $20M private placement with InnovivaN/A
2021-03-11 08:54 ESTNewsInnoviva appoints Ex-Covid Task Force coordinator Birx to BoardN/A
2021-02-22 22:36 ESTNewsBuying Back In To InnovivaN/A
2021-02-04 23:59 ESTFinancialsCompany financials have been released.Neutral
2021-02-04 03:53 ESTEarnings EstimateAn EPS average of $1.51 is estimated for the 2022 year.Buy
2021-02-03 20:55 ESTNewsInnoviva reports Q4 resultsN/A
2021-01-27 16:57 ESTNewsArmata announces capital raise of $20MN/A
2020-11-26 20:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 04:17 ESTAnalyst RatingThe Analyst Target Price has increased from $8 to $10.Neutral
2020-11-07 16:11 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 07:03 ESTNewsInnoviva: Only For Short-Term TradersN/A
2020-11-03 19:58 ESTFinancialsCompany financials have been released.Neutral
2020-11-02 17:49 ESTFinancialsCompany financials have been released.Neutral
2020-10-31 18:58 ESTNewsInnoviva reports Q3 resultsN/A
2020-09-26 13:07 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:14 ESTFinancialsCompany financials have been released.Neutral
2020-09-11 03:23 ESTNewsFDA OKs expanded use of Glaxo's Trelegy Ellipta in asthmaN/A
2020-09-01 17:53 ESTInsider TradeInnoviva, Inc. has directly acquired 4,672,897 shares and currently holds 18,672,897 shares.Buy
2020-08-14 09:10 ESTFinancialsCompany financials have been released.Neutral

About Innoviva, Inc (INVA):

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

INVA Quotes by TradingView

See Advanced Chart

General

  • Name Innoviva, Inc
  • Symbol INVA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 5
  • Last Split Factor1241:1000
  • Last Split Date2014-06-03
  • Fiscal Year EndDecember
  • IPO Date2004-10-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.inva.com
View More

Valuation

  • Trailing PE 5.87
  • Price/Sales (Trailing 12 Mt.) 4
  • Price/Book (Most Recent Quarter) 2.23
  • Enterprise Value Revenue 3.98
  • Enterprise Value EBITDA 3.47
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.69
  • Next Year EPS Estimate $1.49
  • Profit Margin 67%
  • Operating Margin 96%
  • Return on Assets 23%
  • Return on Equity 62%
  • Revenue 336.79 million
  • Earnings Per Share $2.02
  • Revenue Per Share $3.32
  • Gross Profit 335.01 million
  • Quarterly Earnings Growth 19.1%
View More

Highlights

  • Market Capitalization 1.2 billion
  • EBITDA 322.84 million
  • PE Ratio 8.34
  • PEG Ratio 0.24
  • Analyst Target Price $10
  • Book Value Per Share $5.33
View More

Share Statistics

  • Shares Outstanding 101.39 million
  • Shares Float 54.79 million
  • % Held by Insiders 3197%
  • % Held by Institutions 75.88%
  • Shares Short 9.96 million
  • Shares Short Prior Month 9.42 million
  • Short Ratio 16.86
  • Short % of Float 17%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 0.65
  • 52 Week High $15.62
  • 52 Week Low $8.13
  • 50 Day Moving Average 11.92
  • 200 Day Moving Average 11.36
View More

Dividends

  • Dividend Date 2015-09-30
  • ExDividend Date 2015-09-08
  • Dividend Per Share $N/A
  • Dividend Yield 0%
View More

Innoviva, Inc (INVA) Dividend Calendar:

INVA's last dividend payment was made to shareholders on September 30, 2015.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Innoviva, Inc (INVA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-03$N/A$0.55$0.4038.7%
2020-09-302020-10-28$88.69 million$0.46$0.429.9%
2020-06-302020-07-29$78.95 million$0.33$0.324.63%
2020-03-312020-04-29$78.68 million$0.42$0.3615.5%
2019-12-312020-02-05$75.97 million$0.42$0.50-15.15%
2019-09-302019-10-30$65.76 million$0.36$0.37-1.37%
2019-06-302019-07-24$64.11 million$0.34$0.42-19.05%
2019-03-312019-05-01$55.18 million$0.31$0.36-13.89%
2018-12-312019-02-06$79.86 million$0.60$0.65-8.09%
2018-09-302018-10-31$61.68 million$0.44$0.424.21%
2018-06-302018-07-26$67.09 million$0.49$0.55-10.91%
2018-03-312018-04-26$52.38 million$0.30$0.55-45.25%
2017-12-312018-02-08$69.52 million$0.48$0.49-2.33%
2017-09-302017-10-25$48.64 million$0.28$0.33-14.56%
2017-06-302017-07-26$58.56 million$0.30$0.292.28%
2017-03-312017-04-27$40.49 million$0.15$0.28-45.95%
2016-12-312017-02-09$43.61 million$0.22$0.22-1.12%
2016-09-302016-10-27$33.31 million$0.13$0.20-35.8%
2016-06-302016-07-28$32.47 million$0.13$0.13-2.99%
2016-03-312016-04-28$24.18 million$0.04$0.08-47.85%
2015-12-312016-02-03$22.84 million$0.04$0.02166.67%
2015-09-302015-10-28$13.56 million-$0.04-$0.03-33.33%
2015-06-302015-07-29$10.66 million-$0.07-$0.06-16.67%
2015-03-312015-05-06$6.9 million-$0.09-$0.08-12.5%
2014-12-312015-02-18$6.34 million-$0.14-$0.140%
2014-09-302014-10-30$999000-$0.19-$0.15-26.67%
2014-06-302014-08-06$934000-$0.57-$0.44-29.55%
2014-03-312014-05-07$165000-$0.62-$0.53-16.98%
2013-12-312014-02-06$1.65 million-$0.46-$0.38-21.05%
2013-09-302013-10-24$415000-$0.44-$0.7944.3%
2013-06-302013-07-25$1.32 million-$0.37-$0.4619.57%
2013-03-312013-04-25$1.32 million-$0.38-$0.380%
2012-12-312013-02-12$5.8 million-$0.33-$0.4119.51%
2012-09-302012-10-30$1.43 million-$0.37-$0.395.13%
2012-06-302012-07-31$1.43 million-$0.42-$0.432.33%
2012-03-312012-04-26$127.1 million$0.93$0.8410.71%
2011-12-312012-02-09$5.36 million-$0.45-$0.39-15.38%
2011-09-302011-10-27$6.43 million-$0.37-$0.33-12.12%
2011-06-302011-07-28$6.39 million-$0.31-$0.28-10.71%
2011-03-312011-04-28$6.33 million-$0.28-$0.280%
2010-12-312011-02-15$6.94 million-$0.25-$0.2810.71%
2010-09-302010-10-21$5.3 million-$0.29-$0.27-7.41%
2010-06-302010-07-22$6.27 million-$0.28-$0.280%
2010-03-312010-04-21$5.71 million-$0.35-$0.29-20.69%
2009-12-312010-02-11$3.82 million-$0.35-$0.33-6.06%
2009-09-302009-10-27$5.52 million-$0.35-$0.34-2.94%
2009-06-302009-07-23$5.49 million-$0.35-$0.350%
2009-03-312009-04-22$9.54 million-$0.31-$0.323.13%
2008-12-312009-02-12$5.95 million-$0.26-$0.3627.78%
2008-09-302008-10-23$6 million-$0.34-$0.352.86%
2008-06-302008-07-24$5.51 million-$0.44-$0.4910.2%
2008-03-312008-04-21$5.65 million-$0.49-$0.48-2.08%
2007-12-312008-02-14$5.63 million-$0.54-$0.551.82%
2007-09-302007-10-25$5.67 million-$0.53-$0.6315.87%
2007-06-302007-07-26$5.31 million-$0.75-$0.68-10.29%
2007-03-312007-04-26$5.4 million-$0.82-$0.67-22.39%
2006-12-312007-02-08$4.93 million-$0.63-$0.641.56%
2006-09-302006-10-26$5.52 million-$0.63-$0.630%
2006-06-302006-07-27$4.84 million-$0.70-$0.756.67%
2006-03-312006-04-27$4.3 million-$0.86-$0.69-24.64%
2005-12-312006-02-09$3.38 million-$0.79-$0.70-12.86%
2005-09-302005-10-27$3.01 million-$0.71-$0.60-18.33%
2005-06-302005-07-27$2.91 million-$0.60-$0.611.64%
2005-03-312005-05-04$2.76 million-$0.59-$0.56-5.36%
2004-12-312005-02-16$2.74 million-$0.56-$0.45-24.44%

Innoviva, Inc (INVA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A 1.01 million 559000 N/A N/A
Income Before Tax N/A 50.49 million 118.12 million 94.88 million 70.27 million
Selling General Administrative N/A 3.25 million 2.6 million 2.56 million 2.33 million
Gross Profit N/A N/A N/A N/A 75.97 million
Ebit N/A 58.55 million 126.14 million 102.86 million 73.64 million
Operating Income N/A 84.43 million 75.79 million 76.12 million 73.64 million
Income Tax Expense 15.74 million N/A 19.89 million 15.93 million 12.4 million
Total Revenue N/A 88.69 million 78.95 million 78.68 million 75.97 million
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A -29.38 million 46.73 million 21.98 million -3.37 million
Net Income From Continuing Operations N/A 41.62 million 98.23 million 78.95 million 57.86 million
Net Income Applicable to Common Shares 53.9 million N/A 76.84 million 65.44 million 45.95 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -8.5 million -7 million 16.04 million N/A -15.94 million
Change to Liabilities N/A 73000 112000 N/A -1.1 million
Total Cash Flow from Investing Activities N/A -7 million 16.04 million N/A -15.94 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities -12000 -11.63 million -15.64 million N/A -10.47 million
Change to Operating Activities N/A 2.77 million -2.47 million N/A -2.64 million
Change in Cash 66.05 million 61.17 million 73.89 million N/A 30.99 million
Total Cash from Operating Activities 74.56 million 79.79 million 73.48 million N/A 57.4 million
Depreciation 3.46 million 3.46 million 3.46 million N/A -136000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables -9.75 million -268000 -2.71 million N/A -1.65 million
Other Cash Flow from Financing Activities N/A -11.81 million -15.81 million N/A -10.55 million
Change to Net Income N/A -5.16 million 7.61 million N/A 17.7 million
Capital Expenditures N/A N/A 13000 N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A 387.38 million 386.81 million 382.14 million 382.71 million
Total Stockholder Equity N/A 485.56 million 456.91 million 379.54 million 313.5 million
Other Current Liabilities 1.96 million N/A N/A N/A 1.22 million
Total Assets N/A 922.26 million 879.62 million 788.01 million 724.83 million
Common Stock 539.91 million N/A 1.02 million 1.01 million 313.5 million
Other Current Assets 95.57 million N/A N/A N/A 80.39 million
Retained Earnings N/A -775.91 million -804.12 million -880.97 million N/A
Other Liabilities 106000 N/A 163000 192000 219000
Other Assets 219.23 million N/A 250.78 million 274.15 million 293.56 million
Cash N/A 479.19 million 413.15 million 351.98 million 350.85 million
Total Current Liabilities 6.11 million 3.9 million 5.41 million 2.8 million 5.37 million
Other Stockholder Equity N/A N/A -2000 33000 N/A
Property, Plant & Equipment 28000 N/A 37000 42000 33000
Total Current Assets 342.06 million 572.04 million 500.19 million 466.91 million 431.23 million
Long Term Investments N/A 111.75 million 128.61 million 46.92 million N/A
Net Tangible Assets 539.91 million N/A 456.91 million 379.54 million 313.5 million
Short Term Investments N/A N/A 4 million 31.97 million N/A
Long Term Debt N/A 383.35 million 381.23 million 379.15 million 377.12 million
Inventory N/A N/A N/A N/A N/A
Accounts Payable N/A 623000 195000 122000 N/A

Innoviva, Inc (INVA) Chart:

Innoviva, Inc (INVA) News:

Below you will find a list of latest news for Innoviva, Inc (INVA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Innoviva, Inc (INVA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-03-212.50CALL0 0284.92TRUE00
2025-03-2150CALL0 0176.8TRUE00
2025-03-217.50CALL0 093.96TRUE00
2025-03-21100CALL0 0111.11TRUE00
2025-03-2112.56.7CALL0 2074.55TRUE00
2025-03-21154.9CALL0 1153.05TRUE00
2025-03-2117.53.28CALL0 1242.71TRUE00
2025-03-21201.78CALL0 541.66FALSE00
2025-03-2122.50.97CALL0 80FALSE00
2025-03-21250.25CALL0 1030FALSE00
2025-03-21300.15CALL0 10FALSE00
2025-03-21350.23CALL0 10FALSE00
2025-03-212.50PUT0 00FALSE00
2025-03-2150PUT0 00FALSE00
2025-03-217.50PUT0 00FALSE00
2025-03-21100PUT0 00FALSE00
2025-03-2112.50PUT0 00FALSE00
2025-03-21150.36PUT0 1043.67FALSE00
2025-03-2117.50.7PUT0 20FALSE00
2025-03-21200PUT0 00TRUE00
2025-03-2122.50PUT0 026.99TRUE00
2025-03-21250PUT0 028.32TRUE00
2025-03-21300PUT0 041.42TRUE00
2025-03-21350PUT0 075.18TRUE00

Latest INVA Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$14.41
Jun 13, 2022 7:59 PM EST800$14.4
Jun 13, 2022 7:59 PM EST800$14.4
Jun 13, 2022 7:59 PM EST800$14.4
Jun 13, 2022 7:59 PM EST800$14.4

Innoviva, Inc (INVA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920012108/0001567619-20-012108-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1080014/000021545719001472/0000215457-19-001472-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1080014/000031506618001322/0000315066-18-001322-index.htm
2018-05-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1080014/000031506618001899/0000315066-18-001899-index.htm
2018-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1080014/000031506618002166/0000315066-18-002166-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1080014/000083423720002190/0000834237-20-002190-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000089914018000502/0000899140-18-000502-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000089914019000271/0000899140-19-000271-index.htm
2020-02-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1080014/000089914020000160/0000899140-20-000160-index.htm
2020-03-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1080014/000089914020000223/0000899140-20-000223-index.htm
2020-04-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1080014/000089914020000256/0000899140-20-000256-index.htm
2020-05-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000089914020000275/0000899140-20-000275-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000089914020000296/0000899140-20-000296-index.htm
2020-06-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1080014/000089914020000297/0000899140-20-000297-index.htm
2020-08-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1080014/000089914020000388/0000899140-20-000388-index.htm
2020-09-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1080014/000089914020000390/0000899140-20-000390-index.htm
2018-04-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1080014/000090342318000211/0000903423-18-000211-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1080014/000093247119005687/0000932471-19-005687-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1080014/000103738919000054/0001037389-19-000054-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1080014/000103738920000211/0001037389-20-000211-index.htm
2018-02-2310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1080014/000104746918001016/0001047469-18-001016-index.htm
2018-03-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1080014/000104746918002075/0001047469-18-002075-index.htm
2019-02-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1080014/000104746919000541/0001047469-19-000541-index.htm
2019-03-13DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1080014/000104746919001164/0001047469-19-001164-index.htm
2020-03-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1080014/000104746920001393/0001047469-20-001393-index.htm
2018-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465918013439/0001104659-18-013439-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465918026177/0001104659-18-026177-index.htm
2018-04-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465918026920/0001104659-18-026920-index.htm
2018-05-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1080014/000110465918030346/0001104659-18-030346-index.htm
2018-05-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465918035150/0001104659-18-035150-index.htm
2018-05-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000110465918035176/0001104659-18-035176-index.htm
2018-07-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465918047404/0001104659-18-047404-index.htm
2018-07-2610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1080014/000110465918047409/0001104659-18-047409-index.htm
2018-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465918049209/0001104659-18-049209-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465918050536/0001104659-18-050536-index.htm
2018-08-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000110465918051627/0001104659-18-051627-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465918059564/0001104659-18-059564-index.htm
2018-10-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465918060588/0001104659-18-060588-index.htm
2018-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465918065090/0001104659-18-065090-index.htm
2018-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1080014/000110465918065095/0001104659-18-065095-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465919006095/0001104659-19-006095-index.htm
2019-02-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1080014/000110465919010200/0001104659-19-010200-index.htm
2019-03-13DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1080014/000110465919014478/0001104659-19-014478-index.htm
2019-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465919023738/0001104659-19-023738-index.htm
2019-05-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1080014/000110465919026029/0001104659-19-026029-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465919026035/0001104659-19-026035-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000110465919031860/0001104659-19-031860-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000110465919031861/0001104659-19-031861-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000110465919031862/0001104659-19-031862-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000110465919031863/0001104659-19-031863-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000110465919031864/0001104659-19-031864-index.htm
2019-07-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465919041604/0001104659-19-041604-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465919057805/0001104659-19-057805-index.htm
2019-10-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1080014/000110465919057833/0001104659-19-057833-index.htm
2020-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465920011253/0001104659-20-011253-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1080014/000110465920018639/0001104659-20-018639-index.htm
2020-02-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1080014/000110465920022807/0001104659-20-022807-index.htm
2020-02-2110-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1080014/000110465920023924/0001104659-20-023924-index.htm
2020-03-12DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1080014/000110465920032462/0001104659-20-032462-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465920041154/0001104659-20-041154-index.htm
2020-03-31DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1080014/000110465920041158/0001104659-20-041158-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465920052385/0001104659-20-052385-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465920053353/0001104659-20-053353-index.htm
2020-04-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1080014/000110465920053388/0001104659-20-053388-index.htm
2020-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465920087855/0001104659-20-087855-index.htm
2020-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465920087865/0001104659-20-087865-index.htm
2020-07-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1080014/000110465920087867/0001104659-20-087867-index.htm
2020-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000110465920118974/0001104659-20-118974-index.htm
2020-10-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1080014/000110465920118989/0001104659-20-118989-index.htm
2018-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018002075/0001179110-18-002075-index.htm
2018-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018002078/0001179110-18-002078-index.htm
2018-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018002079/0001179110-18-002079-index.htm
2018-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018002082/0001179110-18-002082-index.htm
2018-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018002083/0001179110-18-002083-index.htm
2018-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018002084/0001179110-18-002084-index.htm
2018-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018002588/0001179110-18-002588-index.htm
2018-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018002589/0001179110-18-002589-index.htm
2018-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018002590/0001179110-18-002590-index.htm
2018-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018003601/0001179110-18-003601-index.htm
2018-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018003602/0001179110-18-003602-index.htm
2018-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018003604/0001179110-18-003604-index.htm
2018-04-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018005883/0001179110-18-005883-index.htm
2018-04-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018005884/0001179110-18-005884-index.htm
2018-04-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018005885/0001179110-18-005885-index.htm
2018-04-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018005886/0001179110-18-005886-index.htm
2018-04-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018005892/0001179110-18-005892-index.htm
2018-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018007379/0001179110-18-007379-index.htm
2018-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018007382/0001179110-18-007382-index.htm
2018-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000117911018007383/0001179110-18-007383-index.htm
2019-07-2410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1080014/000141057819000553/0001410578-19-000553-index.htm
2019-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1080014/000141057819001285/0001410578-19-001285-index.htm
2018-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761918001671/0001567619-18-001671-index.htm
2018-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761918001672/0001567619-18-001672-index.htm
2018-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761918001673/0001567619-18-001673-index.htm
2018-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761918002412/0001567619-18-002412-index.htm
2018-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761918006845/0001567619-18-006845-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919004979/0001567619-19-004979-index.htm
2019-02-224/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919005281/0001567619-19-005281-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919005282/0001567619-19-005282-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919005283/0001567619-19-005283-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919005601/0001567619-19-005601-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919005602/0001567619-19-005602-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919006226/0001567619-19-006226-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919006227/0001567619-19-006227-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919012022/0001567619-19-012022-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919017438/0001567619-19-017438-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919018002/0001567619-19-018002-index.htm
2019-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761919022045/0001567619-19-022045-index.htm
2020-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920003975/0001567619-20-003975-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920004695/0001567619-20-004695-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920004698/0001567619-20-004698-index.htm
2020-02-254/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920004807/0001567619-20-004807-index.htm
2020-02-254/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920004808/0001567619-20-004808-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920007226/0001567619-20-007226-index.htm
2020-04-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920008352/0001567619-20-008352-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920008542/0001567619-20-008542-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920008543/0001567619-20-008543-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920008544/0001567619-20-008544-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920008545/0001567619-20-008545-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920008547/0001567619-20-008547-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920011000/0001567619-20-011000-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920011002/0001567619-20-011002-index.htm
2020-05-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920011355/0001567619-20-011355-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920012108/0001567619-20-012108-index.htm
2020-08-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920015897/0001567619-20-015897-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1080014/000156761920016247/0001567619-20-016247-index.htm

Innoviva, Inc (INVA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Innoviva, Inc (INVA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3197%
Institutional Ownership: 7588%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-02-12Mark DiPaoloDirectorBuy10,517.0010,517.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018002084/0001179110-18-002084-index.htm
2018-02-12Sarah J. SchlesingerDirectorBuy10,517.0010,517.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018002082/0001179110-18-002082-index.htm
2020-06-11Innoviva, Inc.10% Share HolderBuy12,677,490.002.5031,693,725.0014,000,000.00https://www.sec.gov/Archives/edgar/data/1080014/000156761920012108/0001567619-20-012108-index.htm
2019-02-19GEOFFREY HULMEInterim PEOBuy9,000.0016,000.00https://www.sec.gov/Archives/edgar/data/1080014/000156761919004979/0001567619-19-004979-index.htm
2019-02-26Marianne ZhenChief Accounting OfficerSell5,617.0016.0089,872.0018,664.00https://www.sec.gov/Archives/edgar/data/1080014/000156761919005601/0001567619-19-005601-index.htm
2020-09-01Innoviva, Inc.10% Share HolderBuy4,672,897.002.6812,499,999.4818,672,897.00https://www.sec.gov/Archives/edgar/data/1080014/000156761920016247/0001567619-20-016247-index.htm
2018-02-21Theodore J. Jr. WitekSr. VP & Chief Scientific Off.Sell9,890.0016.60164,148.29187,573.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018002590/0001179110-18-002590-index.htm
2020-02-24Marianne ZhenChief Accounting OfficerSell2,954.0014.7843,660.1221,913.00https://www.sec.gov/Archives/edgar/data/1080014/000156761920004695/0001567619-20-004695-index.htm
2018-02-12Jules HaimovitzDirectorBuy10,517.0022,717.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018002083/0001179110-18-002083-index.htm
2018-09-07Marianne ZhenChief Accounting OfficerBuy1,779.0023,347.00https://www.sec.gov/Archives/edgar/data/1080014/000156761918002412/0001567619-18-002412-index.htm
2018-02-21GEORGE B ABERCROMBIESr. VP & Chief Comm. OfficerSell8,000.0016.51132,100.00235,473.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018002588/0001179110-18-002588-index.htm
2018-04-24Mark DiPaoloDirectorBuy14,249.0024,766.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018005884/0001179110-18-005884-index.htm
2018-04-24Sarah J. SchlesingerDirectorBuy14,249.0024,766.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018005885/0001179110-18-005885-index.htm
2018-08-21Theodore J. Jr. WitekSr. VP & Chief Scientific Off.Sell8,504.0014.12120,079.88247,767.00https://www.sec.gov/Archives/edgar/data/1080014/000156761918001671/0001567619-18-001671-index.htm
2018-03-02Theodore J. Jr. WitekSr. VP & Chief Scientific Off.Buy74,444.00262,017.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018003601/0001179110-18-003601-index.htm
2019-03-01Marianne ZhenChief Accounting OfficerBuy8,154.0026,818.00https://www.sec.gov/Archives/edgar/data/1080014/000156761919006227/0001567619-19-006227-index.htm
2019-03-01GEOFFREY HULMEInterim PEOBuy14,677.0027,584.00https://www.sec.gov/Archives/edgar/data/1080014/000156761919006226/0001567619-19-006226-index.htm
2018-08-21GEORGE B ABERCROMBIESr. VP & Chief Comm. OfficerSell8,000.0014.11112,840.00285,479.00https://www.sec.gov/Archives/edgar/data/1080014/000156761918001672/0001567619-18-001672-index.htm
2018-04-24George BickerstaffDirectorBuy14,249.0028,762.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018005883/0001179110-18-005883-index.htm
2018-04-24Kostas D OdysseasDirectorBuy14,249.0028,762.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018005892/0001179110-18-005892-index.htm
2018-02-21Eric dEsparbesInterim PEO, SVP and CFOSell5,378.0016.5288,825.20291,810.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018002589/0001179110-18-002589-index.htm
2018-05-21GEORGE B ABERCROMBIESr. VP & Chief Comm. OfficerSell8,000.0014.40115,202.40299,159.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018007382/0001179110-18-007382-index.htm
2018-03-02GEORGE B ABERCROMBIESr. VP & Chief Comm. OfficerBuy74,444.00309,917.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018003602/0001179110-18-003602-index.htm
2019-09-04GEOFFREY HULMEInterim PEOBuy3,000.0010.8932,684.4031,000.00https://www.sec.gov/Archives/edgar/data/1080014/000156761919018002/0001567619-19-018002-index.htm
2018-04-24Jules HaimovitzDirectorBuy14,249.0036,966.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018005886/0001179110-18-005886-index.htm
2018-05-21Eric dEsparbesSVP and CFOSell5,808.0014.4083,623.00373,081.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018007383/0001179110-18-007383-index.htm
2018-03-02Eric dEsparbesInterim PEO, SVP and CFOBuy93,056.00384,866.00https://www.sec.gov/Archives/edgar/data/1080014/000117911018003604/0001179110-18-003604-index.htm
2019-02-21George BickerstaffDirectorBuy10,000.0014.90148,958.0038,762.00https://www.sec.gov/Archives/edgar/data/1080014/000156761919005282/0001567619-19-005282-index.htm
2019-04-24Mark DiPaoloDirectorBuy16,399.0041,165.00https://www.sec.gov/Archives/edgar/data/1080014/000110465919031863/0001104659-19-031863-index.htm
2019-04-24Sarah J. SchlesingerDirectorBuy16,399.0041,165.00https://www.sec.gov/Archives/edgar/data/1080014/000110465919031861/0001104659-19-031861-index.htm
2019-04-24Kostas D OdysseasDirectorBuy16,399.0045,161.00https://www.sec.gov/Archives/edgar/data/1080014/000110465919031862/0001104659-19-031862-index.htm
2019-04-24Jules HaimovitzDirectorBuy16,399.0053,365.00https://www.sec.gov/Archives/edgar/data/1080014/000110465919031864/0001104659-19-031864-index.htm
2019-02-27George BickerstaffDirectorBuy15,000.0015.90238,500.0053,762.00https://www.sec.gov/Archives/edgar/data/1080014/000156761919005602/0001567619-19-005602-index.htm
2020-04-24Mark DiPaoloDirectorBuy16,917.0058,082.00https://www.sec.gov/Archives/edgar/data/1080014/000156761920008543/0001567619-20-008543-index.htm
2020-04-24Sarah J. SchlesingerDirectorBuy16,917.0058,082.00https://www.sec.gov/Archives/edgar/data/1080014/000156761920008542/0001567619-20-008542-index.htm
2020-04-24Kostas D OdysseasDirectorBuy16,917.0062,078.00https://www.sec.gov/Archives/edgar/data/1080014/000156761920008547/0001567619-20-008547-index.htm
2019-02-15GEOFFREY HULMEInterim PEOBuy7,000.0014.80103,600.007,000.00https://www.sec.gov/Archives/edgar/data/1080014/000156761919004979/0001567619-19-004979-index.htm
2019-04-24George BickerstaffDirectorBuy16,399.0070,161.00https://www.sec.gov/Archives/edgar/data/1080014/000110465919031860/0001104659-19-031860-index.htm
2020-04-24Jules HaimovitzDirectorBuy16,917.0070,282.00https://www.sec.gov/Archives/edgar/data/1080014/000156761920008544/0001567619-20-008544-index.htm
2020-04-24George BickerstaffDirectorBuy16,917.0087,078.00https://www.sec.gov/Archives/edgar/data/1080014/000156761920008545/0001567619-20-008545-index.htm
2020-03-27Innoviva, Inc.10% Share HolderBuy7,717,661.002.8722,149,687.078,710,800.00https://www.sec.gov/Archives/edgar/data/1080014/000156761920007226/0001567619-20-007226-index.htm